In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

General Motors has beaten revenue and earnings per share estimates from analysts in each of the last 9 straight quarters.

GM to report Q4 earnings on Jan. 28. Wall Street expects $1.86 EPS and $43.61B revenue. FTC action and job cuts may impact ...

The United States has long been the “Land of Opportunity.” That has been true since our founding and remained through ...

General Motors and subsidiary OnStar have been banned for five years from sharing the precise geolocation and driving ...

In its continued concentration on the collection and use of consumers’ precise geolocation, on January 16, 2024, the Federal Trade Commission ...

GM and OnStar are facing intense scrutiny over data collection practices, with more than two dozen new lawsuits filed over ...

Recent lawsuits allege driver data from embedded auto technology and mobile apps is being used unethically and illegally.

Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, ...

Khan said. In a move to protect consumer privacy, the FTC has taken action against General Motors and its OnStar division for ...

GM touts OnStar as a service that will help consumers during an emergency and provide hands-free voice assistance and ...

Retail media might not ruin retail, but the strikes are adding up. Plus, TikTok throws its support behind Trump.